Abstract
6534 Background: The evolution of targeted therapy in NSCLC has led to growing complexity of clinical research and a heightened expectation of clinical benefit for participants. Clinical trials in ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have